This may be due in part to the difficulty of smoking cessation
This can progress to NASH, causing inflammation and damage, potentially leading to cirrhosis or liver cancer
Dual-Action MechanismActivates both GIP and GLP-1 receptors to suppress appetite and improve metabolic function
Device and technique questions should go to the prescriber or the product's Instructions for Use
Conclusions In these post hoc analyses, in participants with obesity or overweight, tirzepatide was associated with reduced blood pressure consistently across participant groups primarily via weight loss, with relatively few blood pressure-related adverse events
Christian KH, Petitti C, Ortega-Schwartz K, Mulder E, Noppe A, von der Wiesche M, et al